Ayseguel Ilhan-Mutlu (Aysegul Ilhan-Mutlu, Aysegül Ilhan-Mutlu)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Epidermal Growth Factor Receptor

Endoplasmic Reticulum

Oral Anticoagulants

Metastatic Colorectal Cancer

Top Venues

Journal of cancer research and clinical oncology

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah Christina Puhr, Thorsten J Reiter, Matthias Preusser, Gerald W Prager, Ayseguel Ilhan-Mutlu
Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer. Cancers 15 (6) (2023)
Hannah Christina Puhr, Clemens C Weirauch, Flora Selimi, Karin Oberreiter, Martin A Dieterle, Gerd Jomrich, Sebastian F Schoppmann, Gerald W Prager, Anna Sophie Berghoff, Matthias Preusser, Ayseguel Ilhan-Mutlu
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma. Journal of cancer research and clinical oncology (2023)
Hannah Christina Puhr, Thorsten J Reiter, Matthias Preusser, Gerald W Prager, Ayseguel Ilhan-Mutlu
Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer. Cancers 15 (6) (2023)
Hannah C Puhr, Ayseguel Ilhan-Mutlu, Matthias Preusser, Peter Quehenberger, Paul A Kyrle, Sabine Eichinger, Lisbeth Eischer
Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy. Pharmaceutics 14 (3) (2022)
Hannah Christina Puhr, Eleonore Pablik, Anna Sophie Berghoff, Gerd Jomrich, Sebastian Friedrich Schoppmann, Matthias Preusser, Ayseguel Ilhan-Mutlu
Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome. ESMO open 5 (2) (2021)
Hannah Christina Puhr, Matthias Preusser, Ayseguel Ilhan-Mutlu
Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021? Cancers 13 (18) (2021)
Hannah Christina Puhr, Ayseguel Ilhan-Mutlu
Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. Journal of cancer research and clinical oncology 147 (5) (2021)
Hannah C Puhr, Thorsten J Reiter, Mohamed El-Mahrouk, Lena Saliternig, Peter Wolf, Maximilian J Mair, Ariane Steindl, Matthias Paireder, Reza Asari, Sebastian F Schoppmann, Anna S Berghoff, Matthias Preusser, Ayseguel Ilhan-Mutlu
Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis. Cancers 13 (20) (2021)
Maximilian J Mair, Ayseguel Ilhan-Mutlu, Sahra Pajenda, Barbara Kiesel, Adelheid Wöhrer, Georg Widhalm, Karin Dieckmann, Christine Marosi, Ludwig Wagner, Matthias Preusser, Anna Sophie Berghoff
Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma. Cancer immunology, immunotherapy : CII 70 (12) (2021)
Andrea Beer, Hossein Taghizadeh, Ana-Iris Schiefer, Hannah C Puhr, Alexander K Karner, Gerd Jomrich, Sebastian F Schoppmann, Renate Kain, Matthias Preusser, Ayseguel Ilhan-Mutlu
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study. Pathology oncology research : POR 26 (4) (2020)
Hannah Christina Puhr, Alexander Karner, Hossein Taghizadeh, Gerd Jomrich, Sebastian Friedrich Schoppmann, Matthias Preusser, Ayseguel Ilhan-Mutlu
Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. Journal of cancer research and clinical oncology 146 (12) (2020)
Hannah Christina Puhr, Ayseguel Ilhan-Mutlu
New emerging targets in cancer immunotherapy: the role of LAG3. ESMO open 4 (2) (2019)
H C Puhr, P Wolf, A S Berghoff, S F Schoppmann, M Preusser, Ayseguel Ilhan-Mutlu
Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis. Hormones & cancer 11 (1) (2019)